Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director
(WorldNews Health)

CHICAGO, June 23, 2017/PRNewswire/ -- Eton Pharmaceuticals, Inc., a development stage pharmaceutical company, today announced the hiring of Sean Brynjelsenas its Chief Executive Officer. Mr. Brynjelsen will develop and execute a strategy to drive near and long-term growth through the development of Eton`s branded product candidate pipeline and by acquiring and in-licensing new products. Mr. Brynjelsen has over 20 years of leadership experience in the pharmaceutical industry with companies including Sagent Pharmaceuticals, Akorn Pharmaceuticals, Hospira and Baxter. Most recently, he served as Executive Vice President of Business Development for Sagent, which was recently acquired by Nichi-Iko...